Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia ( <scp>dVIN</scp> ): an international reproducibility study

Our findings indicate that p53-IHC is a robust ancillary tool that can be reproducibly interpreted by pathologists with varying experience levels and supports the routine use of p53-IHC in cases where dVIN is considered in the differential diagnosis.

Authors

Institutions

Publication Details

Journal
Histopathology
Published
2025-08-05
DOI
https://doi.org/10.1111/his.15524
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia ( dVIN ): an international reproducibility study

Jennifer M. Roberts, Anne‐Sophie Van Rompuy, James Scurry, Shatavisha Dasgupta et al.
Histopathology
Cervical Cancer and HPV Research
article

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia ( dVIN ): an international reproducibility study

Jennifer M. Roberts, Anne‐Sophie Van Rompuy, James Scurry, Shatavisha Dasgupta, Demaretta Rush, Patricia Guzmán, Koen Van de Vijver, Patricia C. Ewing‐Graham, Lex A. C. F. Makkus, Mieke Van Bockstal, Folkert J. van Kemenade, Maaike C.G. Bleeker, Loes Kooreman, Debra S. Heller, Kathleen Lambein, Katy R. Veprauskas, Joost Bart, Senada Koljenović, Rupali Arora, María del Carmen Luís Álvarez, Radhika Srinivasan, Suzanne Wilhelmus, Maria Angelica Selim, F. Plantier, Christine Bergeron, Russell Ball, Mahfooz Basha Mohamed, Noel Jean‐Christophe
article en

Abstract

Our findings indicate that p53-IHC is a robust ancillary tool that can be reproducibly interpreted by pathologists with varying experience levels and supports the routine use of p53-IHC in cases where dVIN is considered in the differential diagnosis.

HistopathologyVol. 88(2)
Rutgers, The State University of New Jersey (US), Broad Institute (US), Cliniques Universitaires Saint-Luc (BE), University Medical Center Groningen (NL), University College London Hospitals NHS Foundation Trust (GB), University of Arizona (US), University of Antwerp (BE), University of North Carolina at Greensboro (US), Duke University (US), University of New Hampshire at Manchester (US), John Hunter Hospital (AU), Ghent University Hospital (BE), Erasmus MC (NL), Erasmus Hospital (BE), Maastricht University (NL), Hôpital Cochin (FR), Douglass Hanly Moir Pathology (AU), Cancer Research Institute Ghent (BE), Duke Medical Center (US), PathoFinder (Netherlands) (NL), Computer Emergency Response Team (FR), Dordrecht Hospital (ZA), Amsterdam University Medical Centers (NL), AZ Sint-Lucas (BE), University College London (GB), Post Graduate Institute of Medical Education and Research (IN), University of Newcastle Australia (AU), Vrije Universiteit Amsterdam (NL), KU Leuven (BE)
Partnerships for the goals
Openalex Percentile: Top 72%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.